Type and Press enter

ORIGINATORS

Originators are developed after many years of laboratory and clinical research and they are subject to strict regulations that ensure their quality, safety and effectiveness.

READ MORE
TRADE NAMEACTIVE INGREDIENTTHERAPEUTIC CLASSIFICATION
NipentPentostatinAntineoplastic drug
TeysunoTegafur, Gimeracil, OteracilAntineoplastic drug

The aforementioned drugs are prescribed and should be used only following medical guidance and always according to the approved by the National Organization for Medicines guidelines (EOF).


GENERICS

Providing safe generics gives patients who would not be able to buy the originator, access to effective treatment, while it saves a great amount of money for the national health system and releases the resources for more expensive treatments.

READ MORE
TRADE NAMEACTIVE INGREDIENTTHERAPEUTIC CLASSIFICATION
Vancomycin Hydrochloride / HospiraVancomycin HydrochlorideSystemically administered antibiotics
LonderAnastrozoleEndocrine treatment
Oxaliplatin/HospiraOxaliplatinAntineoplastic drug
Irinotecan Hydrocloride Trihydrate / HospiraIrinotecan Hydrochloride TrihydrateAntineoplastic drug
Carboplatin / HospiraCarboplatinAntineoplastic drug
GemcipenGemcitabine HydrochlorideAntineoplastic drug
LetropenLetrozoleEndocrine treatment
Paclitaxel / HospiraPaclitaxelAntineoplastic drug
Topotecan / HospiraTopotecanAntineoplastic drug
Docetaxel / HospiraDocetaxelAntineoplastic drug
Cisplatin / HospiraCisplatinAntineoplastic drug
RidocaTemozolomideAntineoplastic drug
Zoledronic Acid HospiraZoledronic Acid MonohydrateDrug for bone disease treatment
Paricalcitol / HospiraParicalcitolDrug for calcium homeostasis
Levetiracetam HospiraLevetiracetamAntiepileptic
Imatinib / AenorasisImatinibOncology, Haematology

The aforementioned drugs are prescribed and should be used only following medical guidance and always according to the approved by the National Organization for Medicines guidelines (EOF).


BIOSIMILARS

Introducing Biosimilars in the international pharmaceutical market improves patients' access to effective treatments, it allows the medical community to provide cost-effective choices and it reduces significantly the total cost of treatment and of the total pharmaceutical expenditure.

READ MORE
TRADE NAMEACTIVE INGREDIENTTHERAPEUTIC CLASSIFICATION
RetacritEpoetin ZetaDrug for Aneamia
NivestimFilgrastimImmunostimulative agent
InflectraInfliximabImmunosuppresant agent

The aforementioned drugs are prescribed and should be used only following medical guidance and always according to the approved by the National Organization for Medicines guidelines (EOF).


RADIOPHARMACEUTICALS

Nuclear Medicine studies the structure and the metabolism of human tissues, with the use of radiopharmaceuticals and radioisotopes. It is an important, rapidly changing sector, which develops products vital to human health.

READ MORE
DIAGNOSIS

— Diagnostic Radiopharmaceuticals and Radioisotopes

SPECT (Single Photon Emission Computed Tomography) Radiopharmaceuticals and radioisotopes. They are administered intravenously and selectively absorbed by the organs and tissues, providing useful information for the assessment of organ function and for the diagnosis of possible failures.

CLASSIFICATION (PER INDICATION)
Adrenal glands/Kidneys

NORCHOL-131
PENTACIS
RENOCIS

Cardiovascular system

STAMICIS
THALLIUM (201TL) CHLORIDE/ΕΝΟΡΑΣΙΣ

Bones

TECEOS

Lungs

PENTACIS
PULMOCIS

Inflammation/Infection

GA-67-MM-1
SCINTIMUN

Others

TEKCIS

CLASSIFICATION (PER PRODUCT GROUP)
Radioisotopes & Radiopharmaceuticals

GA-67-MM-1
NORCHOL-131
THALLIUM (201TL) CHLORIDE/ΕΝΟΡΑΣΙΣ
TEKCIS

Cold kits

PENTACIS
PULMOCIS
RENOCIS
SCINTIMUN
STAMICIS
TECEOS
PHYTACIS

— Radio-immuno-assays (RIA)

In vitro radioisotopes are used to quantify the level of various substances (tumor markers, proteins) in biological fluids (blood, serum, plasma, saliva, urine).

CLASSIFICATION (PER INDICATION)
Auto-immunity

TR-AB-CT (Anti-TSH Receptor Autoantibodies
21-OH-AB (21-Hydroxylase Autoantibodies)
GAD-AB (Anti-GAD Autoantibodies)
IA2-AB (Anti-IA2 Autoantibodies)
AAI (Insulin Autoantibodies)
TPO-AB-CT (TPO Autoantibodies)
MSK/TR (Musk)
TG-AB I STEP (Thyroglobulin Autoantibodies)
VGKC/25 (VGKC Autoantibodies)

Fertility / Reproduction / Hypothalamic-Pituitary axis

ELSA-ACTH (Adreno-corticotropic hormone)
R-GM-100 (Androstenedione)
21-OH-AB (21-Hydroxylase Autoantibodies)
CORT-CT2 (Cortisol)
ESTR-CTRIA (Estradiol)
ESTR-US-CT (Estradiol Ultrasensitive)
OCPM03-HCG (human Chorionic Gonadotropine)
ELSA-FβHCG (Free β hCG – β chains)
OHP-CT (17 OH-Progesterone)
17-OHP-NN (17 OH-Progesterone Neonatal)
TESTO-CT2 (Testosterone)

Diabetes

IA2-AB (Anti-IA2 Autoantibodies)
AAI (Insulin Autoantibodies)
GAD-AB (Anti-GAD Autoantibodies)
IRMA-C-PEP (C-Peptide)
BI-INS-IRMA (Insulin IRMA)
INSULIN-CT (Insulin)

Endocrinology / Hypertension

ALDO-RIACT (Aldosterone)
REN-CT2 (Angiotensin I)
RENINE (Renin)

Thyroid

TG-AB I STEP (Thyroglobulin Autoantibodies)
TR-AB-CT (Anti-TSH Receptor Autoantibodies
TPO-AB-CT (TPO Autoantibodies)
IRMA-HCT (Calcitonin)
OCPE07-T3 (Tri-iodo-thyronine 100 tubes)
OCPE57-T3 (Tri-iodo-thyronine 500 tubes)
OCFH07-FT3 (Free tri-iodo-thyronine 100 tubes)
OCFH57-FT3 (Free tri-iodo-thyronine 500 tubes)
OCPG07-T4 (Thyroxine 100 tubes)
OCPG57-T4 (Thyroxine 500 tubes)
OCFD03-FT4 (Free thyroxine 100 tubes)
OCFD57-FT4 (Free thyroxine 500 tubes)
OCRU03-TBG (TBG)
THYRO (Thyroglobulin)
OCPL07-TSH (Thyroid stimulating hormone, 100 tubes)
OCPL57-TSH (Thyroid stimulating hormone, 500 tubes)
ELSA-TSH-NN (TSH Neonatal)

Oncology

ELSA2-AFP (αlpha fetoprotein)
ELSA-FβHCG (Free β hCG – β chains)
IRMA-HCT (Calcitonin)
ELSA-CA 125II (CA 125)
ELSA-CA 15-3 (CA 15-3)
ELSA-CA 19-9 (CA 19-9)
OCFM07-CA50 (CA 50)
ELSA-CA 72-4 (CA 72-4)
CEA-RIACT (CEA)
CGA-RIACT (Chromogranin A)
ELSA-CYFRA (Cyfra 21-1)
ELSA-NSE (NSE)
PSA-RIACT (PSA total)
FPSA-RIACT (PSA free)
THYRO (Thyroglobulin)

Bone/Growth

HGH-RIACT (Human Growth Hormone)
IGF1 (IGF1)
OSTEO-RIACT (Osteocalcin)
ELSA-PTH (PTH)

Others

GASK-PR (Gast)

TREATMENT

— Therapeutic radiopharmaceuticals

Therapeutic radiopharmaceuticals which have the advantage of concentrating on the pathogenesis and administering energy, without damaging healthy tissues and without burdening the organism with toxins.

CLASSIFICATION (PER INDICATION)
Joints

ERMM-1 (Erbium 169 citrate)
ΥΜΜ-1 (Υttrium 90 citrate)
RE-186-MM-1 (Rhenium 186 sulphide)

Bones

QUADRAMET (Samarium 153 Lexidronam pentasodium)


Με την περιήγησή σας στο aenorasis.com αποδέχεστε την χρήση cookies. περισσότερα

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close